ANTIREFLUX RESECTION OF MUCOUS MEMBRANE OF ESOPHAGOGASTRIC ANASTOMOSIS IN TREATMENT OF BARRETT’S ESOPHAGUS: INITIAL EXPERIENCE
https://doi.org/10.24884/0042-4625-2016-175-4-59-61
Abstract
Antireflux resection of mucous membrane of esophagogastric anastomosis (ARMS) was performed on 6 patients with typical symptoms of gastroesophageal reflux disease (GERD). The patients had a short segment of сolumnar-celled metaplasia (1-2 cm) without radiological and endoscopic signs of hiatal hernia. All the patients received medicamentous therapy by antisecretory agents more than 3 years. The operation included the endoscopic resection of2/3 circle of mucous membrane of esophagogastric anastomosis and resection of the area of columnar-celled metaplasia. The results of treatment were assessed during 3-7 months after ARMS. There was noted an absence of clinical manifestations of GERD, regression of inflammatory signs of mucous coat of esophagus in 4 out of 6 patients. Symptoms of GERD remained in 2 patients, although the intensity of signs significantly decreased.
About the Authors
A. A. Smirnov
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
D. I. Vasilevskiy
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
A. S. Lapshin
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
S. Yu. Dvoretskiy
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
D. I. Filippov
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
A. Z. Tsitskarava
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
S. F. Bagnenko
I. P.Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
References
1. Anderson L., Murray L., Murphy S. et al. Mortality in Barrett’s oeso phagus: results from a population based study // Gut. 2003. Vol. 52. P. 1081-1084.
2. Antoniou S., Koch O., Kaindlstorfer A. et al. Endoscopic full-thickness plication versus laparoscopic fundoplication: a prospective study on quality of life and symptom control // Surg. Endosc. 2012. Vol. 26. P. 1063-1068.
3. Bani-Hani K., Bani-Hani B. Columnar-lined esophagus: time to drop the eponym of «Barrett»: historical review // J. Gastroenterol. Hepatol. 2008. Vol. 23. P. 707-715.
4. Barnes W., Hoddinott K., Mundy S. et al. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice // Surg. Innov. 2011. Vol. 18. P. 119-129.
5. Caygill C., Watson A., Lao-Sirieix P. et al. Barrett’s oesophagus and adenocarcinoma // W. J. Surg. Oncol. 2004. Vol. 2. P. 1-21.
6. Fitzgerald R., di Pietro M., Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus // Gut. 2014. Vol. 63. P. 7-63.
7. Hofstetter W., Peters J., DeMeester T. et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus // Ann. Surg. 2011. Vol. 234. P. 532-539.
8. Inoue H., Ito Y., Ikeda H. et al. Antireflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study // Ann. Gastroenterol. 2014. Vol. 27. P. 346-351.
9. Löfdahl H., Lu Y., Lagergren P., Lagergren J. Risk factors for esophageal adenocarcinoma after antireflux surgery // Ann. Surg. 2013. Vol. 257. P. 579-582.
10. Maret-Ouda J, Konings P., Lagergren J., Brusselaers N. Antireflux surgery and risk of esophageal adenocarcinoma: a systematic review and meta-analysis // Ann. Surg. 2016. Vol. 263. P. 251-257.
11. Melhado R., Alderson D., Tucker O. The changing face of esophageal cancer // Cancers. 2010. Vol. 2. P. 1379-1404.
12. Mudan S., Kang J-Y. Epidemiology and clinical presentation in esophageal cancer // Cambridge University Press. 2008. P. 1-10.
13. Narsule C., Burch M., Ebright M. et al. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience // J. Thorac. Cardiovasc. Surg. 2012. Vol. 143. P. 228-234.
14. Ozawa S., Kumai K., Higuchi K. et al. Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan // J. Gastroenterol. 2009. Vol. 44. P. 675-684.
15. Shaheen N., Falk G., Iyer P., Gerson L. ACG Clinical Guideline: diagnosis and management of Barrett’s esophagus // Am. J. Gastroenterol. 2016. Vol. 111. P. 30-50.
16. Sharma P. Barrett’s esophagus // N. Engl. J. Med. 2009. Vol. 361. P. 2548-2556.
17. Spechler S., Sharma P., Souza R. et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus // Gastroenterology. 2011. Vol. 140. P. 1084-1091.
18. Stefanidis D., Hope W., Kohn G. et al. Guidelines for surgical treat ment of gastroesophageal reflux disease // Surg. Endosc. 2010. Vol. 24. P. 2647-2669.
19. Testoni P., Vailati C., Testoni S. et al. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome // Surg. Endosc. 2012. Vol. 26. P. 1425-1435.
20. Wang K., Sampliner R. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus // Am. J. Gastroenterol. 2008. Vol. 103. P. 788-797.
Review
For citations:
Smirnov A.A., Vasilevskiy D.I., Lapshin A.S., Dvoretskiy S.Yu., Filippov D.I., Tsitskarava A.Z., Bagnenko S.F. ANTIREFLUX RESECTION OF MUCOUS MEMBRANE OF ESOPHAGOGASTRIC ANASTOMOSIS IN TREATMENT OF BARRETT’S ESOPHAGUS: INITIAL EXPERIENCE. Grekov's Bulletin of Surgery. 2016;175(4):59-61. (In Russ.) https://doi.org/10.24884/0042-4625-2016-175-4-59-61
Views:
547
Email this article 